PANNONE LOPES DEVEREAUX & O'GARA LLC

Lobbying for AMGEN · Biotechnology company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · $9,000.00 income · posted Jul 1, 2026

Lobbying activity 1

Pharmacy

Prescription drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem